Verve Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.8M | 203k | 13.94 |
| 2023-09-30 | $1.1M | 83k | 13.26 |
| 2023-06-30 | $1.7M | 88k | 18.75 |
| 2023-03-31 | $1.3M | 91k | 14.42 |
| 2022-12-31 | $4.7M | 244k | 19.35 |
| 2022-09-30 | $1.2M | 34k | 34.27 |
| 2022-06-30 | $2.0k | 150 | 13.33 |
| 2022-03-31 | $2.4M | 106k | 22.64 |
| 2021-12-31 | $898k | 24k | 36.92 |
| 2021-09-30 | $155k | 3.3k | 46.97 |
| 2021-06-30 | $92k | 1.5k | 60.26 |